Abstract
Biomarker discovery is a crucial part of the fast developing field of personalized medicine. Antibody-based techniques including immunostaining of tissue samples are widely used for biomarker evaluation in preclinical and clinical studies. When used in conjunction with robust image analysis methods, it provides a powerful means to assess biomarker modulation, toxicity, and patient response to targeted agents. Here, we describe the optimization of immunofluorescent (IF) staining protocols and a sample IF multiplex protocol suitable for colocalization image analysis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Straus SE, Sackett DL (1999) Applying evidence to the individual patient. Ann Oncol 10:29–32
Khleif S, Doroshow J, Hait W (2010) N.AACR-FDA-NCI cancer biomarkers collaborative. AACR-FDA-NCI cancer biomarkers collaborative consensus report: advancing the use of biomarkers in cancer drug development. Clin Cancer Res 16:3299–3318
Walk E (2010) Improving the power of diagnostics in the era of targeted therapy and personalized healthcare. Curr Opin Drug Discov Devel 13:226–234
Lee J, Devanarayan V, Barrett Y et al (2006) Fit-for-purpose method development and validation for successful biomarker measurement. Pharm Res 23:312–328
Kummar S, Kinders R, Gutierrez M et al (2009) Phase 0 clinical trial of poly (ADP-ribose) polymerase inhibitor ABT-888 in patients with advanced malignancies. J Clin Oncol 27:2705–2711
Coons A, Creech H, Jones R (1941) Immunological properties of an antibody containing a fluorescent group. Proc Soc Exp Biol Med 47:200–202
Dunstan R, Wharton K, Quigley C et al (2011) The use of immunocytochemistry for biomarker assessment-can it compete with other technologies? Toxicol Pathol 39:988–1002
Rizzardi A, Johnson A, Vogel R et al (2012) Quantitative comparison of immunohistochemical staining measured by digital image analysis versus pathologist visual scoring. Diagn Pathol 7:42–52
Mosedale D, Metcalfe C, Grainger D (1996) Optimization of immunofluorescence methods by quantitative image analysis. J Histochem Cytochem 44:1043–1050
Wahlby C, Erlandsson F, Nyberg K et al (2001) Multiple tissue antigen analysis by sequential immunofluorescence staining and multi-dimensional image analysis. Proceeding of SCIA, pp 25–31
Molyneux G, Smalley M (2011) The cell of origin of BRCA1 mutation-associated breast cancer: a cautionary tale of gene expression profiling. J Mammary Gland Biol Neoplasia 16:51–59
Chen G, Gharib T, Huang C et al (2002) Discordant protein and mRNA expression in lung adenocarcinomas. Mol Cell Proteomics 4:304–313
Cummings J, Ward T, Dive C (2010) Fit-for-purpose biomarker validation for anticancer drug development. Drug Discov Today 15:816–825
Mass R (2006) erb-B2 as a therapeutic target. In: Gasparini G, Hayes D (eds) Biomarkers of breast cancer. Humana Press, Towtowa, NJ, p 15973
Wolff A, Hammond M, Schwartz J et al (2007) American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. Arch Pathol Lab Med 131:18–43
Petty H (2007) Fluorescence microscopy: established and emerging methods, experimental strategies, and applications in immunology. Microsc Res Tech 70:687–709
Spring K (2003) Fluorescence microscopy. In: Encyclopedia of optical engineering. Mercel and Dekker, New York, NY, pp 548–555
Michalet X, Kapanidis A, Laurence T et al (2003) The power and prospects of fluorescence microscopes and spectroscopies. Annu Rev Biophys Biomol Struct 32:161–182
Wahlby C, Erlandsson F, Bengtsson E et al (2002) Sequential immunofluorescence staining and image analysis for detection of large numbers of antigens in individual cell nuclei. Cytometry 47:32–41
Spruessel A, Steimann G, Jung M et al (2004) Tissue ischemia time affects gene and protein expression patterns within minutes following surgical tumor excision. BioTechniques 36:1030–1037
Atkins D, Reiffen K, Tegtmeier C et al (2004) Immunohistochemical detection of EGFR in paraffin embedded tumor tissues: variation in staining intensity due to choice of fixative and storage time of tissue sections. J Histochem Cytochem 7:893–901
Burns J, Li Y, Cheney C et al (2009) Choice of fixative is crucial to successful immunohistochemical detection of phosphoproteins in paraffin-embedded tumor tissues. J Histochem Cytochem 57:257–264
Samaratunga H, Montironi R, True L et al (2011) International Society of Urological Pathology (ISUP) consensus conference on handling and staging of radical-prostatectomy specimens. Working group 1: specimen handling. Mod Pathol 24:5–15
Best S, Sawyers Y, Fu V (2007) Integrity of prostatic tissue for molecular analysis after robotic-assisted laparoscopic and open prostatectomy. Urology 70:328–332
Xie R, Chung J, Ylaya K et al (2011) Factors influencing the degradation of archival formalin-fixed paraffin-embedded tissue sections. J Histochem Cytochem 59:356–365
Institute of Laboratory Animal Resources CoLS, National Research Council (1996) Guide for the care and use of laboratory animals. National Academy Press, Washington, D.C., p 125
Goldenthal K, Hedman K, Chen J et al (1985) Postfixation detergent treatment for immunofluorescence suppresses localization of some integral membrane proteins. J Histochem Cytochem 33:813–820
Golubeva Y, Rogers K (2009) Collection and preparation of rodent tissue samples for histopathological and molecular studies in carcinogenesis. Methods Mol Biol 511:3–60
Fox C, Johnson F, Whiting J et al (1985) Formaldehyde fixation. J Histochem Cytochem 33:845–853
Puchtler H, Meloan S (1985) On the chemistry of formaldehyde fixation and its effects on immunohistochemical reactions. Histochemistry 82:201–204
Hann B, Balmain A (2001) Building ‘validated’ mouse models of human cancer. Curr Opin Cell Biol 13:778–784
Atkinson B, Walden B (eds) (1985) Changes in eukaryotic gene expression in response to environmental stress. Imprint Orlando Academic, Orlando, p 379
Mori N, Mizuno D, Goto S (1978) Increase in ratio of 18S RNA to 28 S RNA in cytoplasm of mouse tissues during aging. Mech Ageing Dev 8:285–297
Ross J (1995) mRNA stability in mammalian cells. Microbiol Rev 59:423–450
Kabnick K, Housman D (1998) Determinants that contribute to cytoplasmic stability of human c-fos and beta-globin mRNAs are located at several sites in each RNA. Mol Cell Biol 8:8–13
Melan M, Sluder G (1992) Redistribution and differential extraction of soluble proteins in permeabilized cultured cells: implications for immunofluorescence microscopy. J Cell Sci 101:731–743
Babic A, Loftin I, Stanislaw S et al (2010) The impact of pre-analytical processing on staining quality for H&E, dual hapten, dual color in situ hybridization and fluorescent in situ hybridization assays. Methods 52:287–300
Little E (2010) What difference does a difference make? Visions Conference. http://digitalpathologyassociation.org/_data/files/2010_Presentations/Little_-_What_Difference_Does_A_Difference_Make.ppt
Taylor C, Levenson R (2006) Quantification of immunohistochemistry-issues concerning methods, utility and semiquantitative assessment II. Histopathology 49:411–424
Davis A, Richter A, Becker S et al (2014) Characterizing and diminishing autofluorescence in formalin-fixed paraffin-embedded human respiratory tissue. J Histochem Cytochem 62:405–423
Myers J (2006) Antigen retrieval: a review of commonly used methods and devices. MLO Med Lab Obs 38:10–15
Shaner N, Steinbach P, Tsien R (2005) A guide to choosing fluorescent proteins. Nat Methods 2:905–909
Pawley J (1995) Handbook of biological confocal microscopy. Plenum Press, New York
Fluorescence quantum yields (QY) and lifetimes (Τ) for Alexa fluor dyes–Table 1.5 | Thermo Fisher Scientific (2016) http://www.thermofisher.com. Accessed 31 Mar 2016
Huang B (2012) Flourescent microscopy II. Fluorescent dyes. http://huanglab.ucsf.edu/Lectures/2012%20UCSF%20Fluorescence%20dyes.pdf. Accessed 31 Mar 2016
Burry R (2010) Immunocytochemistry. Springer, New York
Lakowicz J (2006) Principles of fluorescence spectroscopy, 3rd edn. Plenum Press, New York
Khoury T, Sait S, Hwang H et al (2009) Delay to formalin fixation effect on breast biomarkers. Mod Pathol 22:1457–1467
Stack E, Wang C, Roman K et al (2014) Multiplexed immunohistochemistry, imaging, and quantitation: a review, with an assessment of tyramide signal amplification, multispectral imaging and multiplex analysis. Methods 70:46–58
Acknowledgments
This Research was supported (in part) by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research. This project has been funded in whole or in part with federal funds from the National Cancer Institute, National Institutes of Health, under Contract No. HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the US government. The authors would like to thank staff of Clinical Pharmacodynamic Biomarkers Program, Applied/Developmental Research Directorate, and also Donna Butcher, Brad Gouker, and Simona Florea of Pathology-Histotechnology Laboratory, Leidos Biomedical Research, Inc., and Frederick National Laboratory for Cancer Research, USA, for technical assistance.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media LLC
About this protocol
Cite this protocol
Lawrence, S.M., Golubeva, Y.G. (2017). Optimization of Immunostaining for Prospective Image Analysis. In: Espina, V. (eds) Molecular Profiling. Methods in Molecular Biology, vol 1606. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-6990-6_16
Download citation
DOI: https://doi.org/10.1007/978-1-4939-6990-6_16
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-6989-0
Online ISBN: 978-1-4939-6990-6
eBook Packages: Springer Protocols